NEW YORK, June 30, 2016 (GLOBE NEWSWIRE) -- COTA, Inc., a health care informatics and precision analytics company, today announced that it has been granted United States Patent Number 9,378,531 for the development of its COTA Nodal Address (CNA) system, the first and only digital patient classification system that transforms prognostically significant attributes into a digital code.
The patented CNA precisely categorizes patient factors, type and stage of cancer and intended therapies to measure treatment outcomes. The CNA also enables the identification of variances in care, provides quality benchmarking, and highlights clear paths for research and discovery.
“COTA’s CNA classification system is a transformative approach to applying ‘Big Data’ to health care,” said Dr. Andrew Pecora, inventor of the technology, founder and executive chairman of COTA and chief innovations officer of Hackensack University Medical Center. “Due to the skyrocketing cost of cancer care, we began our work on the CNA system with a dedicated group of cancer specialists at the John Theurer Cancer Center at Hackensack. We were able to fully develop and test the use of COTA’s CNA classification system in actual clinical practice, where we were able to show increased clinical and economic value.”
“The CNA is going to revolutionize how care is provided, paid for and researched,” said Eric Schultz, CEO of COTA. “Each critical member involved in health care, including the patient, provider, payer and pharmaceutical industry, will benefit from the clear insights COTA’s patented CNA classification system will provide. This is a transformative tool that will result in reducing patient suffering and extending lives while reducing wasteful spending.”
According to the American Institute of Cancer Research, cancer costs $895 billion annually – far more than any other disease – and the pool of resources to pay for those costs are being reduced. Additionally, with an estimated 30 percent of every dollar spent in health care being wasted the stakes for payers and the health care system are high.
COTA's CNA classification system provides a clear path for providers to reduce treatment variance, and thus helps identify, reduce or eliminate wasteful spend. COTA’s CNA architecture is supported by the firm’s proprietary technology, which includes the Influx Platform. Through Influx, COTA acquires, processes and structures all incoming data by extracting key facts from unstructured data. In short, Influx unlocks patient data and enables oncologists to make important diagnostic/care decisions in real time.
Additionally, the CNA system also reduces the processing requirements and time needed to make real-time monitoring of medical providers’ performance more efficient. With precise predictions of when behavioral variance is likely to occur, the CNA assists physicians in accurately interrupting treatment flow to avoid both over- and under-utilization of care.
COTA’s CNA classification system has been developed for all types and stages of cancer and will soon be expanding to increase the value of care for all medical conditions.
About COTA Inc.
COTA is the health care informatics company that builds research-grade, real-world data to exponentially improve outcomes, reduce cost and ensure the right care for the right patient every time. The patented COTA Nodal Address (CNA) is the first and only digital classification system that transforms prognostically significant variables into a digital code—precisely categorizing patient factors, their diseases and intended therapies to measure treatment outcomes, identify variances in care, and to enable quality benchmarking, research, discovery and the successful transition to value-based medicine. For more information, please visit www.oncota.com. COTA—Best Care Made Clear.™